OFREMKO

Serial Number 88639659
606

Registration Progress

Application Filed
Oct 2, 2019
Under Examination
Apr 7, 2020
Approved for Publication
Feb 11, 2020
Published for Opposition
Feb 11, 2020
Registered

Basic Information

Serial Number
88639659
Filing Date
October 2, 2019
Published for Opposition
February 11, 2020
Abandonment Date
November 7, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 7, 2022
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Nov 7, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 7, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 27, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 27, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 27, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 21, 2022 EXT4 S SOU EXTENSION 4 FILED
Mar 21, 2022 EX4G S SOU EXTENSION 4 GRANTED
Sep 18, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 16, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 16, 2021 EXT3 S SOU EXTENSION 3 FILED
Sep 16, 2021 EX3G S SOU EXTENSION 3 GRANTED
Apr 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 7, 2021 EXT2 S SOU EXTENSION 2 FILED
Apr 7, 2021 EX2G S SOU EXTENSION 2 GRANTED
Sep 24, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 22, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 22, 2020 EXT1 S SOU EXTENSION 1 FILED
Sep 22, 2020 EX1G S SOU EXTENSION 1 GRANTED
Jun 14, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 14, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 14, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 7, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2020 PUBO A PUBLISHED FOR OPPOSITION
Feb 11, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2020 DOCK D ASSIGNED TO EXAMINER
Oct 6, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 5, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio-metabolic diseases and disorders
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "OFREMKO" has no meaning in a foreign language.

Classification

International Classes
005